In Hwa Bae
Overview
Explore the profile of In Hwa Bae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seok H, Choi J, Lee D, Shin I, Bae I
Cell Commun Signal
. 2024 Nov;
22(1):532.
PMID: 39501373
Background: Resistance acquired after radiotherapy is directly related to the failure of various cancer treatments, including GBM. Because the mechanism for overcoming radioresistance has not yet been clearly identified, the...
2.
Choi J, Seok H, Lee D, Kwon J, Shin U, Shin I, et al.
J Transl Med
. 2024 Oct;
22(1):980.
PMID: 39472937
Background: Although the representative treatment for colorectal cancer (CRC) is radiotherapy, cancer cells survive due to inherent radioresistance or resistance acquired after radiation treatment, accelerating tumor malignancy and causing local...
3.
Choi J, Seok H, Lee D, Lee E, Kim T, Bae S, et al.
Cell Commun Signal
. 2024 Mar;
22(1):190.
PMID: 38521953
Background: Solid tumors promote tumor malignancy through interaction with the tumor microenvironment, resulting in difficulties in tumor treatment. Therefore, it is necessary to understand the communication between cells in the...
4.
Seok H, Choi J, Lee D, Yi J, Lee H, Bae I
Noncoding RNA Res
. 2023 Dec;
9(1):33-43.
PMID: 38075199
High-dose radiation (HDR) is widely used for cancer treatment, but the effectiveness of low-dose radiation (LDR) in the treatment of various diseases is controversial. Therefore, to safely utilize LDR for...
5.
Seok H, Choi J, Yi J, Bae I
Noncoding RNA Res
. 2023 Jan;
8(2):164-173.
PMID: 36632615
Radiotherapy is widely used for cancer treatment, but paradoxically, it has been reported that surviving cancer cells can acquire resistance, leading to recurrence or metastasis. Efforts to reduce radioresistance are...
6.
Choi J, Seok H, Kim R, Choi M, Lee S, Bae I
Mol Ther Oncolytics
. 2021 Sep;
22:368-379.
PMID: 34553025
Bcl-w, a member of the Bcl-2 family, is highly expressed in various solid tumor, including lung cancer, suggesting that it is involved in cancer cell survival and carcinogenesis. Solid cancer-induced...
7.
Seok H, Choi Y, Choi J, Yi J, Kim E, Choi M, et al.
Mol Ther Nucleic Acids
. 2021 Aug;
25:127-142.
PMID: 34457998
Breast cancer is the most common female cancer in the world. Despite the active research on metastatic breast cancer, the treatment of breast cancer patients is still difficult because the...
8.
Kim S, Choi J, Seok H, Park M, Chung H, Bae I
Mol Ther Nucleic Acids
. 2019 Jul;
17:245-255.
PMID: 31272074
Glioblastoma multiforme (GBM), a particularly aggressive type of malignant brain tumor, has a high mortality rate. Bcl-w, an oncogene, is reported to enhance cell survival, proliferation, epithelial-mesenchymal transition (EMT), migratory...
9.
Kim E, Choi J, Hwang S, Bae I
Mol Ther Nucleic Acids
. 2019 Feb;
14:450-464.
PMID: 30743214
Although radiotherapy has been successfully applied to treat many cancer types, surviving cancer cells often acquire therapeutic resistance, leading to increased risk of local recurrence and distant metastases via modification...
10.
Choi J, Shin H, Bae I
Biochem Biophys Res Commun
. 2018 Oct;
505(4):1134-1140.
PMID: 30318121
Cellular senescence, a distinctive type of irreversible growth arrest, develops in response to various stimuli. Bcl-w, an oncogene and member of the Bcl-2 family, has been reported to promote tumorigenicity...